Medtech funding reached its low point in the first quarter but will slowly pick back up over the rest of 2023, according to a new Pitchbook report. It noted that this year’s medtech funding total will not come close to the $19.7 billion the sector raised in 2021, and it might even come in below last year’s funding total of $13.5 billion.
During Q3, digital health's funding fell 36% quarter-over-quarter and 72% from its all-time high during last year’s Q2. The primary driver of this reduction is macro market trends, experts said, though digital health companies need to tie their services more directly to value to get funding in the future.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
The first ever White House Demo Day designed to exhibit startups looking for venture funding will include two focused on healthcare.
The vast majority of life sciences venture capital went to biotechnology, a PricewaterhouseCoopers report finds.